Latest News and Press Releases

Liestal, Schweiz, 19. Januar 2018 - Santhera Pharmaceuticals (SIX: SANN) erwartet die Beurteilung des Zulassungsantrags für Raxone® bei Duchenne-Muskeldystrophie (DMD) durch das CHMP am 26. Januar...

Liestal, Switzerland, January 19, 2018 - Santhera Pharmaceuticals (SIX: SANN) expects to announce feedback from the CHMP on its Marketing Authorization Application (MAA) for Raxone® in Duchenne...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  WISeKey's WIS.WATCH powered by VaultIC...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} This press release is also available in...

Collaboration aims to help patients worldwide gain access to a range of high-quality, affordable immunology and oncology biologics Partnership will be an important part of Sandoz and Biocon...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  WISeKey to launch The TransHuman Code at...

Communiqué de presse Banque Profil de Gestion SA : Prévisions des résultats annuels 2017 Genève, le 17 janvier 2018 - La Banque Profil de Gestion SA (SIX Swiss Exchange : BPDG) annonce ce qui...

Ascom sichert sich einen Wartungs- und Service-Vertrag über vier Jahre mit dem Krankenhausdistrikt Helsinki und Uusimaa (HUS) in Finnland. Der im zweiten Halbjahr 2017 unterzeichnete Vertrag hat...

Ascom secures a four-year maintenance and service contract with the Hospital District of Helsinki and Uusimaa (HUS) in Finland. The contract signed in the second half of 2017 has a value of around...

Filing acceptance marks second Priority Review granted to Kymriah by the FDA for two distinct indications, underscoring the potential of first ever FDA-approved CAR-T therapy  EMA granted...